`
`.EHA@EIJHE?JJA=IMEJDBK@=JEJ
`FKH?D=IAFEE@=JE@JAEJI
`
`)J=AAJECBJDA=A+KJOFEE@1EJE=JELA=IJMAAF=HJE?EF=JIA=HA@@=JEIMAHACECJ=AKF=IDHJB=E
`
`EJIJHALELAFAFAMDD=LALAH@IA@FEE@IE?=I=
`
`*O.H=5)>@AHD@A
`AMI5K
`
`7; $# #!2
`
`6
`
`DAIKFFOB=H?=EJIFE?A?=HHOJDAFHALELAFAFAMDD=LALAH@IA@=FEE@
`
`M=I@=CAHKIOM=??H@ECJJDA=A+KJO0A=JD,AF=HJAJ>KJJDA=BK@=JE
`
`=@=BEHAFHJA?JE@EIJHE?J?=AJJDAHAI?KA
`
`2KIJDAAMEJIJD=J=HA>AEC>KCDJ=HA@AI?HE>A@>O=@L?=JAI=I=A=IEAH@AELAHO=I=IFH=O
`
`JOFAJD=JM=IB=IJJH=?A@>OJDA75.@=@,HKC)@EEIJH=JE
`
`9A?K@D=LA>AAE@EHAIJH=EJIEBEJM=IJBHJDA.EAH.K@=JEB0ECD=@2=H=@JDA
`
`9=HHA9=KAC=.EHA2HJA?JE,EIJHE?JI=E@5KI=?ECDJ?H@E=JHBHJDA?KJOI
`
`IK>IJ=?A=>KIAFHCH=
`
`DJJF MMM?DE?=CJHE>KA?IK>KH>I=A?KJOAMIIKAMI?JI=H?=@=JE
`
`Opiant Exhibit 2154
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00694
`Page 1
`
`
`
`.EHA@EIJHE?JJA=IMEJDBK@=JEJFKH?D=IAFEE@=JE@JAEJI =A+KJOAMI
`
`2DEEF,A4KJ=JHKIJAAMEJDJDABEHA@EIJHE?JI=E@JD=J=JJDA=IJJDOAAJECBJDA=A
`
`+KJOFEE@1EJE=JELADAA=HA@JDADA=JD@AF=HJAJM=I@MJEJI=IJ#EJI6DA5KI=
`
`/KCCADAEBJDA.EAH.K@=JEIFA=@I=E@BBE?E=IMAHAIJ=HJEC==J?DECCH=JFHCH=
`
`BHEJIKFJ #
`
`1JJDAEBH=JE>=?JO>=H@=@JDAOMAHAA?IJ=JE?JDAFDAI=E@EC=>KJDM
`
`JDABEHA@AF=HJAJM=IDAFECKJJDAFE?A@AF=HJAJ=HA=JEIDEFJD=JEIJ=M=OIIJD
`
`1J@JDAANJAAJECJD=JJDABEHAFHJA?JE@EIJHE?JM=JA@JIKFFHJ=MABH?AAJ=@JDAHA
`
`MAHA=JDAIAFE?A?DEABIJDAHA=@JDAO=KCDA@=@=FF=K@A@DAI=E@
`
`?ECDJI=E@JDAAMEJIMDE?DD=LAJM@AIFAHEJEIBH=?F=O?=A@)@=FJ
`
`2D=H=?AKJE?==@@JD=LAJ>A=IIA>A@EAIAFD=H=?AKJE?=@ALE?AI1J?==I>A
`
`KIA@EKIJAIJHEMDAHAJDAHIAA@D=B=@IAEAIJHE=@D=BE=JDAH
`
`.HJDA=IJJMOA=HIJDADA=JD@AF=HJAJD=IIA?KHA@!EJI=OA=HBH@EIJHE>KJE=CJDA
`
` =MABH?AAJBBE?AHIEJDA?KJOBHJDA8EHCEE=>=IA@=A?F=O*A?=KIAB=
`
`IDHJ=CAJDEIOA=HJDA@AF=HJAJM=IO=>AJFHLE@AEJIMDE?DMAHAJDAEA?J=>AJOFA
`
`/KCCADAEI=E@JDA.EAH.K@=JEM=I?HA=JA@>O=H=@KEA.EAHB0ECD=@2=HMD
`
`IJJDAEH !OA=H@I=BJAHDACJDA@FEE@I=BJAH=IFHJIEKHO0AM=IHALELA@?A=J
`
`DA>OF=H=A@E?I@KHECDEIBECDJMEJDJDA=@@E?JE=@M=IIAJJHAD=>EEJ=JE>KJJDA=BAM
`
`MAAI=BJAHDACJDADA@EA@B=LAH@IA
`
`6DEIM=I==HA=MA?K@=A=EA@E=JAEF=?J=@I=LA=EBAIDAI=E@BJDABK@=JEI
`
`CEBJB"=@JDA=J?DECCH=J?D=ACABKFJ #6DAO=J?DA@JDABEHA@EIJHE?JI
`
`!%#=@D=LAHA?AELA@HA@=JEIBHJDAFHCH=E?K@EC=HA?AJ?JHE>KJE
`
`BH+F=II0A=JDBHJD>H=@&BHJDA8AH0EI2E?A,AF=HJAJ
`
`5DAI=E@JDAO=IMD=LA=JANJEA@=JEIKH?AMDAHAE@ELE@K=I?=?JHE>KJA=O=KJ
`
`>OJANJEC0AH !J""""
`
`;K?=@=JA=@=HEBOKM=J=JDHKCDJDAJANJ/KCCADAEI=E@1JII=@JD=JMAAA@
`
`JDEI>KJMAHAD=FFOJDAF
`
`B=>@AHD@A(JHE>FK>?
`
`6MEJJAH(=>@AHD@A
`
`+FOHECDJ %=A+KJOAMI5K
`
`DJJF MMM?DE?=CJHE>KA?IK>KH>I=A?KJOAMIIKAMI?JI=H?=@=JE
`
`Opiant Exhibit 2154
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00694
`Page 2
`
`